BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
162 hedge funds and large institutions have $419M invested in bluebird bio in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
7% more funds holding
Funds holding: 151 → 162 (+11)
0.4% more ownership
Funds ownership: 3.85% → 4.25% (+0.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
162
Holding in Top 10
1
Calls
$8.09M
Puts
$6.42M
Top Buyers
| 1 | +$69M | |
| 2 | +$9.12M | |
| 3 | +$8.43M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.21M |
| 5 |
BlackRock
New York
|
+$6.87M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$13M | |
| 3 | -$5.33M | |
| 4 |
D.E. Shaw & Co
New York
|
-$3.96M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.45M |